Comparing Active and Passive Recharge Burst Spinal Cord Stimulation for Pain Relief in Persistent Spinal Pain Syndrome Type 2 A Multicenter Randomized Study
Led by Rijnstate Hospital · Updated on 2024-11-19
96
Participants Needed
6
Research Sites
25 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effects of two types of burst spinal cord stimulation SCS on pain relief and emotional aspects of pain in patients with Persistent Spinal Pain Syndrome Type 2 PSPS Type 2, also known as Failed Back Surgery Syndrome. The trial compares active recharge burst SCS versus passive recharge burst SCS, as no prior clinical studies have directly compared these two waveform methods. This randomized clinical trial aims to improve understanding of how different burst waveforms influence pain experience.
The trial enrolls 96 patients across six Dutch hospitals who are randomly assigned to receive either active recharge or passive recharge burst SCS. After a successful trial period, patients will be permanently implanted with the assigned device. Active recharge burst uses negative pulses to directly compensate for charge differences, while passive recharge burst passively compensates for charge differences. Treatments are assessed over 12 months following implantation.
Participants will complete various assessments including the Pain Catastrophizing Scale PCS at 6 months as the primary outcome. Secondary measures include pain ratings, patient vigilance, anxiety and depression scales, quality of life, disability index, patient global impression of change, and painDETECT questionnaires at baseline, after trial, and at 1, 3, 6, and 12 months post-implantation. The study monitors device usage and collects patient-reported outcomes to evaluate differences in pain relief and emotional response.
CONDITIONS
Brief Title
Effects of Active Versus Passive Recharge Burst Spinal Cord Stimulation on Pain Experience in Persistent Spinal Pain Syndrome Type 2: a Multicenter Randomized Trial (BURST-RAP Study)
Research Team
M
Martijn Mons, Msc.
J
Jan-Willem Kallewaard, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
At least moderate level of catastrophizing with a Pain Catastrophizing Scale (PCS) score of at least 20 at first pain clinic visit
Chronic pain diagnosis of Persistent Spinal Pain Syndrome Type 2 (PSPS Type 2) lasting at least 6 months
Neurologic exam without marked motor deficit
Low back pain and/or leg pain intensity of 5 or higher on an 11-point numeric rating scale
Meets all criteria for neurostimulation system implantation as used in the study center
Screened and deemed suitable for implantation by a multi-disciplinary panel including a psychologist
Able and willing to comply with follow-up schedule and study protocol
Able to provide written informed consent
You will not qualify if you...
Female subjects of childbearing potential who are pregnant, nursing, or planning pregnancy during the study
Escalating or changing pain condition within the past month as determined by investigator
Body mass index (BMI) of 35 or higher
Received injection therapy or radiofrequency treatment for low back or leg pain within the past 3 months
Currently has an active implantable device such as ICD, pacemaker, spinal cord stimulator, or intrathecal drug pump
Unable to operate the neurostimulation device
Severe spinal column degeneration likely to cause technical problems with neuromodulation
Previous neurostimulation therapy
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Trial Period and Implantation
Duration - Duration of trial period until permanent implantation
Participants undergo a trial period of spinal cord stimulation using either active or passive recharge burst stimulation. Following a successful trial period, participants are permanently implanted with the neurostimulation device.
1 to 2 visits during trial period and implantation procedure
Treatment
Duration - 12 months following implantation
Participants receive spinal cord stimulation treatment with the implanted device and complete assessments of pain and quality of life at multiple time points.
Visits at baseline, after trial, and at 1, 3, 6, and 12 months post-implantation
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Using the SOMA Smartphone App to Track Mood and Pain Changes in Adults with Acute and Chronic Pain Over Four Months
Comparing Active and Passive Recharge Burst Spinal Cord Stimulation for Pain Relief in Persistent Spinal Pain Syndrome Type 2 A Multicenter Randomized Study
Study of Different Low Back Pain Types on Pain Severity and Quality of Life in Adults with Failed Back Surgery Syndrome
Pilot Study on Improving Walking Using Spinal Stimulation in Adults with Chronic Postoperative Lumbosciatalgia
Study of Nerve Activation Accuracy and Sensation in Patients Using Evoke Closed-loop Spinal Cord Stimulation for Chronic Pain
Evaluation of Open and Closed Loop Differential Target Multiplexed Spinal Cord Stimulation for Persistent Spinal Pain Syndrome Type II A European Multicenter Cohort Study
Improving Return to Work After Spinal Cord Stimulation in Persistent Spinal Pain Syndrome Type II Patients
A Personalized Biopsychosocial Rehabilitation Program Compared to Usual Care
A Multicenter Randomized Controlled Trial
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Study protocol: Effects of active versus passive recharge burst spinal cord stimulation on pain experience in persistent spinal pain syndrome type 2: a multicentre randomized trial (BURST-RAP study).